Other Species / Isoforms
  GR (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S6-p
__MDSKEsLtPGREE
0 1
GR (human) __MDSKEsLtPGREE S6-p
GR iso2 (human) __MDSKESLTPGREE S6
GR iso3 (human) __MDSKESLTPGREE S6
GR iso10 (human) __MDSKESLTPGREE S6
GR (mouse) __MDSKESLAPPGRD S6
GR (rat) __MDSKESLAPPGRD S6
T8-p
MDSKEsLtPGREENP
Upstream
0 5
Treatment
  • BI2536
GR (human) MDSKEsLtPGREENP T8-p
GR iso2 (human) MDSKESLTPGREENP T8
GR iso3 (human) MDSKESLTPGREENP T8
GR iso10 (human) MDSKESLTPGREENP T8
GR (mouse) MDSKESLAPPGRDEV A8
GR (rat) MDSKESLAPPGRDEV A8
R23
SSVLAQERGDVMDFy
0 29
GR (human) SSVLAQERGDVMDFy R23
GR iso2 (human) SSVLAQERGDVMDFY R23
GR iso3 (human) SSVLAQERGDVMDFY R23
GR iso10 (human) SSVLAQERGDVMDFY R23
GR (mouse) SSLLGRGrGSVMDLY R24-m1
GR (rat) GSLLGQGrGSVMDFY R24-m1
Y30-p
RGDVMDFyKtLrGGA
Downstream
1 3
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • protein conformation
GR (human) RGDVMDFyKtLrGGA Y30-p
GR iso2 (human) RGDVMDFYKTLRGGA Y30
GR iso3 (human) RGDVMDFYKTLRGGA Y30
GR iso10 (human) RGDVMDFYKTLRGGA Y30
GR (mouse) rGSVMDLYKTLrGGA Y31
GR (rat) rGSVMDFYKSLRGGA Y31
T32-p
DVMDFyKtLrGGAtV
0 1
GR (human) DVMDFyKtLrGGAtV T32-p
GR iso2 (human) DVMDFYKTLRGGATV T32
GR iso3 (human) DVMDFYKTLRGGATV T32
GR iso10 (human) DVMDFYKTLRGGATV T32
GR (mouse) SVMDLYKTLrGGATV T33
GR (rat) SVMDFYKSLRGGATV S33
R34-m1
MDFyKtLrGGAtVKV
0 22
GR (human) MDFyKtLrGGAtVKV R34-m1
GR iso2 (human) MDFYKTLRGGATVKV R34
GR iso3 (human) MDFYKTLRGGATVKV R34
GR iso10 (human) MDFYKTLRGGATVKV R34
GR (mouse) MDLYKTLrGGATVKV R35-m1
GR (rat) MDFYKSLRGGATVKV R35
T38-p
KtLrGGAtVKVSAss
0 1
GR (human) KtLrGGAtVKVSAss T38-p
GR iso2 (human) KTLRGGATVKVSASS T38
GR iso3 (human) KTLRGGATVKVSASS T38
GR iso10 (human) KTLRGGATVKVSASS T38
GR (mouse) KTLrGGATVKVsASs T39
GR (rat) KSLRGGATVKVSASS T39
S42
GGAtVKVSAssPSLA
0 1
GR (human) GGAtVKVSAssPSLA S42
GR iso2 (human) GGATVKVSASSPSLA S42
GR iso3 (human) GGATVKVSASSPSLA S42
GR iso10 (human) GGATVKVSASSPSLA S42
GR (mouse) GGATVKVsASsPSVA S43-gl
GR (rat) GGATVKVSASSPSVA S43
S44-p
AtVKVSAssPSLAVA
0 9
GR (human) AtVKVSAssPSLAVA S44-p
GR iso2 (human) ATVKVSASSPSLAVA S44
GR iso3 (human) ATVKVSASSPSLAVA S44
GR iso10 (human) ATVKVSASSPSLAVA S44
GR (mouse) ATVKVsASsPSVAAA S45
GR (rat) ATVKVSASSPSVAAA S45
S45-p
tVKVSAssPSLAVAS
Upstream
0 10
Treatment
  • vemurafenib
GR (human) tVKVSAssPSLAVAS S45-p
GR iso2 (human) TVKVSASSPSLAVAS S45
GR iso3 (human) TVKVSASSPSLAVAS S45
GR iso10 (human) TVKVSASSPSLAVAS S45
GR (mouse) TVKVsASsPSVAAAS S46-p
GR (rat) TVKVSASSPSVAAAS S46
S54-p
SLAVASQsDskQRRL
0 1
GR (human) SLAVASQsDskQRRL S54-p
GR iso2 (human) SLAVASQSDSKQRRL S54
GR iso3 (human) SLAVASQSDSKQRRL S54
GR iso10 (human) SLAVASQSDSKQRRL S54
GR (mouse) SVAAASQADSKQQRI A55
GR (rat) SVAAASQADSkQQRI A55
S56-p
AVASQsDskQRRLLV
0 1
GR (human) AVASQsDskQRRLLV S56-p
GR iso2 (human) AVASQSDSKQRRLLV S56
GR iso3 (human) AVASQSDSKQRRLLV S56
GR iso10 (human) AVASQSDSKQRRLLV S56
GR (mouse) AAASQADSKQQRILL S57
GR (rat) AAASQADSkQQRILL S57
K57
VASQsDsKQRRLLVD
0 1
GR (human) VASQsDsKQRRLLVD K57
GR iso2 (human) VASQSDSKQRRLLVD K57
GR iso3 (human) VASQSDSKQRRLLVD K57
GR iso10 (human) VASQSDSKQRRLLVD K57
GR (mouse) AASQADSKQQRILLD K58
GR (rat) AASQADSkQQRILLD K58-ac
K57-sm
VASQsDskQRRLLVD
0 1
GR (human) VASQsDskQRRLLVD K57-sm
GR iso2 (human) VASQSDSKQRRLLVD K57
GR iso3 (human) VASQSDSKQRRLLVD K57
GR iso10 (human) VASQSDSKQRRLLVD K57
GR (mouse) AASQADSKQQRILLD K58
GR (rat) AASQADSKQQRILLD K58
K57-ub
VASQsDskQRRLLVD
0 2
GR (human) VASQsDskQRRLLVD K57-ub
GR iso2 (human) VASQSDSKQRRLLVD K57
GR iso3 (human) VASQSDSKQRRLLVD K57
GR iso10 (human) VASQSDSKQRRLLVD K57
GR (mouse) AASQADSKQQRILLD K58
GR (rat) AASQADSKQQRILLD K58
K67
RLLVDFPKGSVSNAQ
0 1
GR (human) RLLVDFPKGSVSNAQ K67
GR iso2 (human) RLLVDFPKGSVSNAQ K67
GR iso3 (human) RLLVDFPKGSVSNAQ K67
GR iso10 (human) RLLVDFPKGSVSNAQ K67
GR (mouse) RILLDFSKGSASNAQ K68
GR (rat) RILLDFSkGSTSNVQ K68-ac
K67-sm
RLLVDFPkGSVSNAQ
0 1
GR (human) RLLVDFPkGSVSNAQ K67-sm
GR iso2 (human) RLLVDFPKGSVSNAQ K67
GR iso3 (human) RLLVDFPKGSVSNAQ K67
GR iso10 (human) RLLVDFPKGSVSNAQ K67
GR (mouse) RILLDFSKGSASNAQ K68
GR (rat) RILLDFSKGSTSNVQ K68
K67-ub
RLLVDFPkGSVSNAQ
0 2
GR (human) RLLVDFPkGSVSNAQ K67-ub
GR iso2 (human) RLLVDFPKGSVSNAQ K67
GR iso3 (human) RLLVDFPKGSVSNAQ K67
GR iso10 (human) RLLVDFPKGSVSNAQ K67
GR (mouse) RILLDFSKGSASNAQ K68
GR (rat) RILLDFSKGSTSNVQ K68
S79-p
NAQQPDLsKAVSLSM
0 1
GR (human) NAQQPDLsKAVSLSM S79-p
GR iso2 (human) NAQQPDLSKAVSLSM S79
GR iso3 (human) NAQQPDLSKAVSLSM S79
GR iso10 (human) NAQQPDLSKAVSLSM S79
GR (mouse) QQPQPDLSKAVSLSM S88
GR (rat) QQQQPDLSKAVSLSM S100
Y89-p
VSLSMGLyMGEtEtk
0 1
GR (human) VSLSMGLyMGEtEtk Y89-p
GR iso2 (human) VSLSMGLYMGETETK Y89
GR iso3 (human) VSLSMGLYMGETETK Y89
GR iso10 (human) VSLSMGLYMGETETK Y89
GR (mouse) VSLSMGLYMGETETK Y98
GR (rat) VSLSMGLYMGETETK Y110
T93-p
MGLyMGEtEtkVMGN
0 1
GR (human) MGLyMGEtEtkVMGN T93-p
GR iso2 (human) MGLYMGETETKVMGN T93
GR iso3 (human) MGLYMGETETKVMGN T93
GR iso10 (human) MGLYMGETETKVMGN T93
GR (mouse) MGLYMGETETKVMGN T102
GR (rat) MGLYMGETETKVMGN T114
T95-p
LyMGEtEtkVMGNDL
0 1
GR (human) LyMGEtEtkVMGNDL T95-p
GR iso2 (human) LYMGETETKVMGNDL T95
GR iso3 (human) LYMGETETKVMGNDL T95
GR iso10 (human) LYMGETETKVMGNDL T95
GR (mouse) LYMGETETKVMGNDL T104
GR (rat) LYMGETETKVMGNDL T116
K96-sm
yMGEtEtkVMGNDLG
0 1
GR (human) yMGEtEtkVMGNDLG K96-sm
GR iso2 (human) YMGETETKVMGNDLG K96
GR iso3 (human) YMGETETKVMGNDLG K96
GR iso10 (human) YMGETETKVMGNDLG K96
GR (mouse) YMGETETKVMGNDLG K105
GR (rat) YMGETETKVMGNDLG K117
S113
QQGQISLSSGETDLK
3 0
GR (human) QQGQISLSSGETDLK S113
GR iso2 (human) QQGQISLSSGETDLK S113
GR iso3 (human) QQGQISLSSGETDLK S113
GR iso10 (human) QQGQISLSSGETDLK S113
GR (mouse) QQGQLGLsSGETDFR S122-p
GR (rat) QQGQLGLSSGETDFR S134
S125-p
DLKLLEEsIANLNRs
0 1
GR (human) DLKLLEEsIANLNRs S125-p
GR iso2 (human) DLKLLEESIANLNRS S125
GR iso3 (human) DLKLLEESIANLNRS S125
GR iso10 (human) DLKLLEESIANLNRS S125
GR (mouse) DFRLLEESIANLNRS S134
GR (rat) DFRLLEESIANLNRS S146
S132-p
sIANLNRstsVPENP
Upstream
0 2
Treatment
  • BI2536
  • taxol
GR (human) sIANLNRstsVPENP S132-p
GR iso2 (human) SIANLNRSTSVPENP S132
GR iso3 (human) SIANLNRSTSVPENP S132
GR iso10 (human) SIANLNRSTSVPENP S132
GR (mouse) SIANLNRSTSRPENP S141
GR (rat) SIANLNRSTsVPENP S153
T133-p
IANLNRstsVPENPk
0 1
GR (human) IANLNRstsVPENPk T133-p
GR iso2 (human) IANLNRSTSVPENPK T133
GR iso3 (human) IANLNRSTSVPENPK T133
GR iso10 (human) IANLNRSTSVPENPK T133
GR (mouse) IANLNRSTSRPENPK T142
GR (rat) IANLNRSTsVPENPK T154
S134-p
ANLNRstsVPENPkS
Upstream
Downstream
7 17
GR (human)
S134-p
GR iso2 (human)
S134-p
GR iso10 (human)
S134-p
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, altered
  • transcription, induced
  • transcription, inhibited
Kinase, in vitro:
  • Akt1 (human)
Putative in vivo kinases:
  • Akt1 (human)
  • P38A (mouse)
Treatment
  • BI2536
  • compound_C
  • dexamethasone
  • glucose_starvation
  • H2O2
  • hypoxia
  • KT5720
  • LY294002
  • Methylprednisolone
  • osmotic_stress
  • SB203580
  • SP600125
  • triamcinolone
  • UVC
GR (human) ANLNRstsVPENPkS S134-p
GR iso2 (human) ANLNRSTSVPENPKS S134
GR iso3 (human) ANLNRSTSVPENPKS S134
GR iso10 (human) ANLNRSTSVPENPKS S134
GR (mouse) ANLNRSTSRPENPKs S143
GR (rat) ANLNRSTsVPENPKS S155-p
K140-ub
tsVPENPkSSASTAV
0 1
GR (human) tsVPENPkSSASTAV K140-ub
GR iso2 (human) TSVPENPKSSASTAV K140
GR iso3 (human) TSVPENPKSSASTAV K140
GR iso10 (human) TSVPENPKSSASTAV K140
GR (mouse) TSRPENPKsStPAAG K149
GR (rat) TsVPENPKSSTSATG K161
S141
sVPENPkSSASTAVS
2 0
GR (human) sVPENPkSSASTAVS S141
GR iso2 (human) SVPENPKSSASTAVS S141
GR iso3 (human) SVPENPKSSASTAVS S141
GR iso10 (human) SVPENPKSSASTAVS S141
GR (mouse) SRPENPKsStPAAGC S150-p
GR (rat) sVPENPKSSTSATGC S162
A143
PENPkSSASTAVSAA
0 1
GR (human) PENPkSSASTAVSAA A143
GR iso2 (human) PENPKSSASTAVSAA A143
GR iso3 (human) PENPKSSASTAVSAA A143
GR iso10 (human) PENPKSSASTAVSAA A143
GR (mouse) PENPKsStPAAGCAt T152-p
GR (rat) PENPKSSTSATGCAt T164
A150
ASTAVSAAPTEkEFP
7 11
GR (human) ASTAVSAAPTEkEFP A150
GR iso2 (human) ASTAVSAAPTEKEFP A150
GR iso3 (human) ASTAVSAAPTEKEFP A150
GR iso10 (human) ASTAVSAAPTEKEFP A150
GR (mouse) tPAAGCAtPtEKEFP T159-p
GR (rat) TSATGCAtPTEKEFP T171-p
T152
TAVSAAPTEkEFPKT
0 1
GR (human) TAVSAAPTEkEFPKT T152
GR iso2 (human) TAVSAAPTEKEFPKT T152
GR iso3 (human) TAVSAAPTEKEFPKT T152
GR iso10 (human) TAVSAAPTEKEFPKT T152
GR (mouse) AAGCAtPtEKEFPQT T161-p
GR (rat) ATGCAtPTEKEFPKt T173
K154-ac
VSAAPTEkEFPKTHS
0 1
GR (human) VSAAPTEkEFPKTHS K154-ac
GR iso2 (human) VSAAPTEKEFPKTHS K154
GR iso3 (human) VSAAPTEKEFPKTHS K154
GR iso10 (human) VSAAPTEKEFPKTHS K154
GR (mouse) GCAtPtEKEFPQTHS K163
GR (rat) GCAtPTEKEFPKtHS K175
K154-ub
VSAAPTEkEFPKTHS
0 1
GR (human) VSAAPTEkEFPKTHS K154-ub
GR iso2 (human) VSAAPTEKEFPKTHS K154
GR iso3 (human) VSAAPTEKEFPKTHS K154
GR iso10 (human) VSAAPTEKEFPKTHS K154
GR (mouse) GCAtPtEKEFPQTHS K163
GR (rat) GCAtPTEKEFPKtHS K175
T159
TEkEFPKTHSDVsSE
0 1
GR (human) TEkEFPKTHSDVsSE T159
GR iso2 (human) TEKEFPKTHSDVSSE T159
GR iso3 (human) TEKEFPKTHSDVSSE T159
GR iso10 (human) TEKEFPKTHSDVSSE T159
GR (mouse) tEKEFPQTHSDPSSE T168
GR (rat) TEKEFPKtHSDASSE T180-p
S164-p
PKTHSDVsSEQQHLk
0 1
GR (human) PKTHSDVsSEQQHLk S164-p
GR iso2 (human) PKTHSDVSSEQQHLK S164
GR iso3 (human) PKTHSDVSSEQQHLK S164
GR iso10 (human) PKTHSDVSSEQQHLK S164
GR (mouse) PQTHSDPSSEQQNRK S173
GR (rat) PKtHSDASSEQQNRK S185
K171-ub
sSEQQHLkGQTGTNG
0 1
GR (human) sSEQQHLkGQTGTNG K171-ub
GR iso2 (human) SSEQQHLKGQTGTNG K171
GR iso3 (human) SSEQQHLKGQTGTNG K171
GR iso10 (human) SSEQQHLKGQTGTNG K171
GR (mouse) SSEQQNRKsQPGTNG K180
GR (rat) SSEQQNRKSQTGTNG K192
G172
SEQQHLkGQTGTNGG
0 1
GR (human) SEQQHLkGQTGTNGG G172
GR iso2 (human) SEQQHLKGQTGTNGG G172
GR iso3 (human) SEQQHLKGQTGTNGG G172
GR iso10 (human) SEQQHLKGQTGTNGG G172
GR (mouse) SEQQNRKsQPGTNGG S181-p
GR (rat) SEQQNRKSQTGTNGG S193
S203-p
DLEFSSGsPGkEtNE
Upstream
Downstream
17 7
Effects on Modified Protein
  • activity, inhibited
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • transcription, induced
  • transcription, inhibited
Kinase, in vitro:
  • CDK5 (human)
  • P38A (human)
Putative in vivo kinases:
  • CDK5 (human)
  • P38A (human)
Putative upstream phosphatases:
  • PPP5C (human)
Regulatory protein:
  • MKK3 (human)
  • PPP5C (human)
Treatment
  • aphidicolin
  • dexamethasone
  • fluocinolone
  • fluticasone
  • geldanamycin
  • hydroxyurea
  • Methylprednisolone
  • mifepristone
  • nocodazole
  • prednisolone
  • SB203580
  • seliciclib
  • siRNA
  • taxol
  • triamcinolone
  • VX-680
  • ZK299
GR (human) DLEFSSGsPGkEtNE S203-p
GR iso2 (human) DLEFSSGSPGKETNE S203
GR iso3 (human) DLEFSSGSPGKETNE S203
GR iso10 (human) DLEFSSGSPGKETNE S203
GR (mouse) DLEFSAGsPGKETNE S212-p
GR (rat) DLEFSAGsPSKDTNE S224-p
K206-ub
FSSGsPGkEtNEsPW
0 1
GR (human) FSSGsPGkEtNEsPW K206-ub
GR iso2 (human) FSSGSPGKETNESPW K206
GR iso3 (human) FSSGSPGKETNESPW K206
GR iso10 (human) FSSGSPGKETNESPW K206
GR (mouse) FSAGsPGKETNEsPW K215
GR (rat) FSAGsPSKDTNEsPW K227
T208-p
SGsPGkEtNEsPWRS
0 1
GR (human) SGsPGkEtNEsPWRS T208-p
GR iso2 (human) SGSPGKETNESPWRS T208
GR iso3 (human) SGSPGKETNESPWRS T208
GR iso10 (human) SGSPGKETNESPWRS T208
GR (mouse) AGsPGKETNEsPWRS T217
GR (rat) AGsPSKDTNEsPWRS T229
S211-p
PGkEtNEsPWRSDLL
Upstream
Downstream
39 5
GR (human)
S211-p
GR (mouse)
S220-p
Effects on Modified Protein
  • activity, induced
  • activity, inhibited
  • intracellular localization
  • molecular association, regulation
  • protein conformation
  • protein stabilization
Effects on Biological Processes:
  • apoptosis, induced
  • cell cycle regulation
  • transcription, altered
  • transcription, induced
  • transcription, inhibited
Kinase, in vitro:
  • CDK5 (human)
  • P38A (human)
Putative in vivo kinases:
  • CDK5 (human)
  • P38A (human)
Putative upstream phosphatases:
  • PPP5C (human)
Regulatory protein:
  • PPP5C (human)
Treatment
  • amanitin
  • aphidicolin
  • calyculin_A
  • colforsin
  • deacylcortivasol
  • dexamethasone
  • etoposide
  • fluocinolone
  • fluticasone
  • geldanamycin
  • GnRH
  • GSK-3_inhibitor_X
  • hydrocortisone
  • hydroxyurea
  • JNK_inhibitor_VIII
  • Methylprednisolone
  • MG132
  • mifepristone
  • MPA
  • NET-A
  • nocodazole
  • okadaic_acid
  • PD98059
  • prednisolone
  • progesterone
  • rapamycin
  • SB202190
  • SB203580
  • seliciclib
  • siRNA
  • SP600125
  • taxol
  • triamcinolone
  • U0126
  • UV
  • UVC
  • VX-680
  • ZK299
GR (human) PGkEtNEsPWRSDLL S211-p
GR iso2 (human) PGKETNESPWRSDLL S211
GR iso3 (human) PGKETNESPWRSDLL S211
GR iso10 (human) PGKETNESPWRSDLL S211
GR (mouse) PGKETNEsPWRSDLL S220-p
GR (rat) PSKDTNEsPWRSDLL S232-p
S226-p
IDENCLLsPLAGEDD
Upstream
Downstream
33 10
GR (human)
S226-p
GR iso2 (human)
S226-p
GR iso10 (human)
S226-p
GR (mouse)
S234-p
GR (rat)
S246-p
Effects on Modified Protein
  • activity, inhibited
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, induced
  • transcription, inhibited
Kinase, in vitro:
  • CDK5 (human)
  • JNK1 (human)
Putative in vivo kinases:
  • ERK1 (human)
  • JNK1 (human)
  • P38A (human)
  • P38B (human)
Putative upstream phosphatases:
  • PPP5C (human)
Regulatory protein:
  • P38A (human)
  • PPP5C (human)
Treatment
  • amanitin
  • bisindolylmaleimide
  • calyculin_A
  • dexamethasone
  • etoposide
  • fluticasone
  • formoterol
  • geldanamycin
  • GnRH
  • H-89
  • IL-2
  • IL-4
  • iturelix
  • Methylprednisolone
  • MG132
  • PD98059
  • SB203580
  • SP600125
  • triamcinolone
  • UV
GR (human) IDENCLLsPLAGEDD S226-p
GR iso2 (human) IDENCLLSPLAGEDD S226
GR iso3 (human) IDENCLLSPLAGEDD S226
GR iso10 (human) IDENCLLSPLAGEDD S226
GR (mouse) LIDENLLsPLAGEDD S234-p
GR (rat) LIDENLLsPLAGEDD S246-p
S234-p
PLAGEDDsFLLEGNs
0 1
GR (human) PLAGEDDsFLLEGNs S234-p
GR iso2 (human) PLAGEDDSFLLEGNS S234
GR iso3 (human) PLAGEDDSFLLEGNS S234
GR iso10 (human) PLAGEDDSFLLEGNS S234
GR (mouse) PLAGEDDPFLLEGDV P242
GR (rat) PLAGEDDPFLLEGNT P254
S241-p
sFLLEGNsNEDCKPL
0 1
GR (human) sFLLEGNsNEDCKPL S241-p
GR iso2 (human) SFLLEGNSNEDCKPL S241
GR iso3 (human) SFLLEGNSNEDCKPL S241
GR iso10 (human) SFLLEGNSNEDCKPL S241
GR (mouse) PFLLEGDVNEDCKPL V249
GR (rat) PFLLEGNTNEDCKPL T261
K254-sm
PLILPDTkPKIKDNG
0 2
GR (human) PLILPDTkPKIKDNG K254-sm
GR iso2 (human) PLILPDTKPKIKDNG K254
GR iso3 (human) PLILPDTKPKIKDNG K254
GR iso10 (human) PLILPDTKPKIKDNG K254
GR (mouse) PLILPDTKPKIQDtG K262
GR (rat) PLILPDTKPKIkDTG K274
K258
PDTkPKIKDNGDLVL
0 1
GR (human) PDTkPKIKDNGDLVL K258
GR iso2 (human) PDTKPKIKDNGDLVL K258
GR iso3 (human) PDTKPKIKDNGDLVL K258
GR iso10 (human) PDTKPKIKDNGDLVL K258
GR (mouse) PDTKPKIQDtGDtIL Q266
GR (rat) PDTKPKIkDTGDTIL K278-ac
N260
TkPKIKDNGDLVLss
0 1
GR (human) TkPKIKDNGDLVLss N260
GR iso2 (human) TKPKIKDNGDLVLSS N260
GR iso3 (human) TKPKIKDNGDLVLSS N260
GR iso10 (human) TKPKIKDNGDLVLSS N260
GR (mouse) TKPKIQDtGDtILss T268-p
GR (rat) TKPKIkDTGDTILss T280
L263
KIKDNGDLVLssPSN
0 1
GR (human) KIKDNGDLVLssPSN L263
GR iso2 (human) KIKDNGDLVLSSPSN L263
GR iso3 (human) KIKDNGDLVLSSPSN L263
GR iso10 (human) KIKDNGDLVLSSPSN L263
GR (mouse) KIQDtGDtILssPss T271-p
GR (rat) KIkDTGDTILssPSS T283
S266-p
DNGDLVLssPSNVtL
1 3
GR (human) DNGDLVLssPSNVtL S266-p
GR iso2 (human) DNGDLVLSSPSNVTL S266
GR iso3 (human) DNGDLVLSSPSNVTL S266
GR iso10 (human) DNGDLVLSSPSNVTL S266
GR (mouse) DtGDtILssPssVAL S274-p
GR (rat) DTGDTILssPSSVAL S286-p
S267-p
NGDLVLssPSNVtLP
Upstream
2 13
Treatment
  • dexamethasone
  • Methylprednisolone
  • nocodazole
  • triamcinolone
GR (human) NGDLVLssPSNVtLP S267-p
GR iso2 (human) NGDLVLSSPSNVTLP S267
GR iso3 (human) NGDLVLSSPSNVTLP S267
GR iso10 (human) NGDLVLSSPSNVTLP S267
GR (mouse) tGDtILssPssVALP S275-p
GR (rat) TGDTILssPSSVALP S287-p
S269
DLVLssPSNVtLPQV
0 1
GR (human) DLVLssPSNVtLPQV S269
GR iso2 (human) DLVLSSPSNVTLPQV S269
GR iso3 (human) DLVLSSPSNVTLPQV S269
GR iso10 (human) DLVLSSPSNVTLPQV S269
GR (mouse) DtILssPssVALPQV S277-p
GR (rat) DTILssPSSVALPQV S289
N270
LVLssPSNVtLPQVk
0 1
GR (human) LVLssPSNVtLPQVk N270
GR iso2 (human) LVLSSPSNVTLPQVK N270
GR iso3 (human) LVLSSPSNVTLPQVK N270
GR iso10 (human) LVLSSPSNVTLPQVK N270
GR (mouse) tILssPssVALPQVK S278-p
GR (rat) TILssPSSVALPQVk S290
T272-p
LssPSNVtLPQVkTE
0 1
GR (human) LssPSNVtLPQVkTE T272-p
GR iso2 (human) LSSPSNVTLPQVKTE T272
GR iso3 (human) LSSPSNVTLPQVKTE T272
GR iso10 (human) LSSPSNVTLPQVKTE T272
GR (mouse) LssPssVALPQVKTE A280
GR (rat) LssPSSVALPQVkTE A292
K277-sm
NVtLPQVkTEkEDFI
Upstream
Downstream
5 3
Effects on Modified Protein
  • protein degradation
Effects on Biological Processes:
  • transcription, induced
  • transcription, inhibited
Treatment
  • dexamethasone
GR (human) NVtLPQVkTEkEDFI K277-sm
GR iso2 (human) NVTLPQVKTEKEDFI K277
GR iso3 (human) NVTLPQVKTEKEDFI K277
GR iso10 (human) NVTLPQVKTEKEDFI K277
GR (mouse) sVALPQVKTEkDDFI K285
GR (rat) SVALPQVkTEKDDFI K297-sm
K277-ub
NVtLPQVkTEkEDFI
0 1
GR (human) NVtLPQVkTEkEDFI K277-ub
GR iso2 (human) NVTLPQVKTEKEDFI K277
GR iso3 (human) NVTLPQVKTEKEDFI K277
GR iso10 (human) NVTLPQVKTEKEDFI K277
GR (mouse) sVALPQVKTEkDDFI K285
GR (rat) SVALPQVKTEKDDFI K297
K280-ub
LPQVkTEkEDFIELC
0 2
GR (human) LPQVkTEkEDFIELC K280-ub
GR iso2 (human) LPQVKTEKEDFIELC K280
GR iso3 (human) LPQVKTEKEDFIELC K280
GR iso10 (human) LPQVKTEKEDFIELC K280
GR (mouse) LPQVKTEkDDFIELC K288-ub
GR (rat) LPQVkTEKDDFIELC K300
T288-p
EDFIELCtPGVIkQE
0 1
GR (human) EDFIELCtPGVIkQE T288-p
GR iso2 (human) EDFIELCTPGVIKQE T288
GR iso3 (human) EDFIELCTPGVIKQE T288
GR iso10 (human) EDFIELCTPGVIKQE T288
GR (mouse) DDFIELCTPGVIkQE T296
GR (rat) DDFIELCTPGVIkQE T308
K293-sm
LCtPGVIkQEkLGTV
Upstream
Downstream
7 3
Effects on Modified Protein
  • protein degradation
Effects on Biological Processes:
  • transcription, induced
  • transcription, inhibited
Treatment
  • dexamethasone
GR (human) LCtPGVIkQEkLGTV K293-sm
GR iso2 (human) LCTPGVIKQEKLGTV K293
GR iso3 (human) LCTPGVIKQEKLGTV K293
GR iso10 (human) LCTPGVIKQEKLGTV K293
GR (mouse) LCTPGVIkQEKLGPV K301-sm
GR (rat) LCTPGVIkQEKLGPV K313-sm
K293-ub
LCtPGVIkQEkLGTV
0 1
GR (human) LCtPGVIkQEkLGTV K293-ub
GR iso2 (human) LCTPGVIKQEKLGTV K293
GR iso3 (human) LCTPGVIKQEKLGTV K293
GR iso10 (human) LCTPGVIKQEKLGTV K293
GR (mouse) LCTPGVIKQEKLGPV K301
GR (rat) LCTPGVIKQEKLGPV K313
K296-ub
PGVIkQEkLGTVyCQ
0 2
GR (human) PGVIkQEkLGTVyCQ K296-ub
GR iso2 (human) PGVIKQEKLGTVYCQ K296
GR iso3 (human) PGVIKQEKLGTVYCQ K296
GR iso10 (human) PGVIKQEKLGTVYCQ K296
GR (mouse) PGVIkQEKLGPVYCQ K304
GR (rat) PGVIkQEKLGPVYCQ K316
Y301-p
QEkLGTVyCQAsFPG
0 3
GR (human) QEkLGTVyCQAsFPG Y301-p
GR iso2 (human) QEKLGTVYCQASFPG Y301
GR iso3 (human) QEKLGTVYCQASFPG Y301
GR iso10 (human) QEKLGTVYCQASFPG Y301
GR (mouse) QEKLGPVYCQASFsG Y309
GR (rat) QEKLGPVYCQASFSG Y321
S305-p
GTVyCQAsFPGANII
0 2
GR (human) GTVyCQAsFPGANII S305-p
GR iso2 (human) GTVYCQASFPGANII S305
GR iso3 (human) GTVYCQASFPGANII S305
GR iso10 (human) GTVYCQASFPGANII S305
GR (mouse) GPVYCQASFsGTNII S313
GR (rat) GPVYCQASFSGTNII S325
P307
VyCQAsFPGANIIGN
2 0
GR (human) VyCQAsFPGANIIGN P307
GR iso2 (human) VYCQASFPGANIIGN P307
GR iso3 (human) VYCQASFPGANIIGN P307
GR iso10 (human) VYCQASFPGANIIAS P307
GR (mouse) VYCQASFsGTNIIGN S315-p
GR (rat) VYCQASFSGTNIIGN S327
S317-p
NIIGNKMsAISVHGV
0 1
GR (human) NIIGNKMsAISVHGV S317-p
GR iso2 (human) NIIGNKMSAISVHGV S317
GR iso3 (human) NIIGNKMSAISVHGV S317
GR iso10 (human) gap -
GR (mouse) NIIGNKMSAISVHGV S325
GR (rat) NIIGNKMSAISVHGV S337
K348-sm
LSQQQDQkPIFNVIP
0 1
GR (human) LSQQQDQkPIFNVIP K348-sm
GR iso2 (human) LSQQQDQKPIFNVIP K348
GR iso3 (human) LSQQQDQKPIFNVIP K348
GR iso10 (human) LSQQQDQKPIFNVIP K322
GR (mouse) LSQQQDQKPVFNVIP K356
GR (rat) LSQQQDQKPVFNVIP K368
S390-p
FPGRTVFsNGYSSPS
0 1
GR (human) FPGRTVFsNGYSSPS S390-p
GR iso2 (human) FPGRTVFSNGYSSPS S390
GR iso3 (human) FPGRTVFSNGYSSPS S390
GR iso10 (human) FPGRTVFSNGYSSPS S364
GR (mouse) FAGRSVFSNGYSSPG S398
GR (rat) FPGRSVFSNGYSsPG S410
S395
VFsNGYSSPSMRPDV
0 1
GR (human) VFsNGYSSPSMRPDV S395
GR iso2 (human) VFSNGYSSPSMRPDV S395
GR iso3 (human) VFSNGYSSPSMRPDV S395
GR iso10 (human) VFSNGYSSPSMRPDV S369
GR (mouse) VFSNGYSSPGMRPDV S403
GR (rat) VFSNGYSsPGMRPDV S415-p
S404-p
SMRPDVSsPPSSSST
Upstream
Downstream
2 4
Effects on Modified Protein
  • activity, inhibited
  • intracellular localization
  • molecular association, regulation
  • protein conformation
  • protein degradation
Effects on Biological Processes:
  • apoptosis, inhibited
  • transcription, induced
Kinase, in vitro:
  • GSK3B (human)
Putative in vivo kinases:
  • GSK3B (human)
Treatment
  • BIO
  • compound A
  • dexamethasone
  • GSK-3_inhibitor_X
  • hydrocortisone
GR (human) SMRPDVSsPPSSSST S404-p
GR iso2 (human) SMRPDVSSPPSSSST S404
GR iso3 (human) SMRPDVSSPPSSSST S404
GR iso10 (human) SMRPDVSSPPSSSST S378
GR (mouse) GMRPDVSsPPSSSST S412-p
GR (rat) GMRPDVSSPPSSSSA S424
K419
ATTGPPPKLCLVCSD
1 0
GR (human) ATTGPPPKLCLVCSD K419
GR iso2 (human) ATTGPPPKLCLVCSD K419
GR iso3 (human) ATTGPPPKLCLVCSD K419
GR iso10 (human) ATTGPPPKLCLVCSD K393
GR (mouse) TATGPPPkLCLVCSD K426-ub
GR (rat) AATGPPPKLCLVCSD K438
K480-ac
CPACRYRkCLQAGMN
Upstream
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, inhibited
Treatment
  • siRNA
GR (human) CPACRYRkCLQAGMN K480-ac
GR iso2 (human) CPACRYRKCLQAGMN K480
GR iso3 (human) CPACRYRKCLQAGMN K481
GR iso10 (human) CPACRYRKCLQAGMN K454
GR (mouse) CPACRYRKCLQAGMN K487
GR (rat) CPACRYRKCLQAGMN K499
K492-ac
GMNLEARkTkkKIkG
Upstream
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, inhibited
Treatment
  • siRNA
GR (human) GMNLEARkTkkKIkG K492-ac
GR iso2 (human) GMNLEARK